Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle-Reference-Cited by-同舟云学术

Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

Published:2004-07-15 Issue:2 Volume:114 Page:182-195
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Torrente Yvan,Belicchi Marzia,Sampaolesi Maurilio,Pisati Federica,Meregalli Mirella,D’Antona Giuseppe,Tonlorenzi Rossana,Porretti Laura,Gavina Manuela,Mamchaoui Kamel,Pellegrino Maria Antonietta,Furling Denis,Mouly Vincent,Butler-Browne Gillian S.,Bottinelli Roberto,Cossu Giulio,Bresolin Nereo

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference59 articles.

1. A cDNA clone from the Duchenne/Becker muscular dystrophy gene

2. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human MuStem cells are competent to fuse with nonhuman primate myofibers in a clinically relevant transplantation context: A proof-of-concept study;Journal of Neuropathology & Experimental Neurology;2024-05-16

2. MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury;Cellular and Molecular Life Sciences;2024-01-30

3. Clinical Trials of Cell Therapy and Regenerative Medicine in Muscular Dystrophies;Handbook of Stem Cell Applications;2024

4. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons;International Journal of Molecular Sciences;2023-12-12

5. Cell Therapy for Muscular Dystrophy;Potential Therapeutic Strategies for Muscular Dystrophy;2023-11-02